AnaptysBio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. 

CEO
Daniel R. Faga
CEODaniel R. Faga
Employees
104
Employees104
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2005
Founded2005
Employees
104
Employees104

ANAB Key Statistics

Market cap
1.50B
Market cap1.50B
Price-Earnings ratio
-47.79
Price-Earnings ratio-47.79
Dividend yield
Dividend yield
Average volume
604.05K
Average volume604.05K
High today
$53.34
High today$53.34
Low today
$50.59
Low today$50.59
Open price
$52.12
Open price$52.12
Volume
411.08K
Volume411.08K
52 Week high
$72.36
52 Week high$72.36
52 Week low
$12.53
52 Week low$12.53

Stock Snapshot

As of today, AnaptysBio(ANAB) shares are valued at $51.63. The company's market cap stands at 1.5B, with a P/E ratio of -47.79.

As of 2026-06-09, AnaptysBio(ANAB) stock has fluctuated between $50.59 and $53.34. The current price stands at $51.63, placing the stock +2.1% above today's low and -3.2% off the high.

The AnaptysBio(ANAB)'s current trading volume is 411.08K, compared to an average daily volume of 604.05K.

In the last year, AnaptysBio(ANAB) shares hit a 52-week high of $72.36 and a 52-week low of $12.53.

In the last year, AnaptysBio(ANAB) shares hit a 52-week high of $72.36 and a 52-week low of $12.53.

ANAB News

Investing.com 5d
AnaptysBio earnings up next: First report as royalty company - Investing.com

...

AnaptysBio earnings up next: First report as royalty company - Investing.com
Simply Wall St 5d
AnaptysBio Shifts Fiscal Year-End As Volatile Stock Eyes Growth Forecasts

AnaptysBio (NasdaqGS:ANAB) has approved a change in its fiscal year-end from December 31 to June 30. The new fiscal year-end is expected to affect the timing o...

AnaptysBio Shifts Fiscal Year-End As Volatile Stock Eyes Growth Forecasts

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.